Member news

Teva Donates Medicines to Treat Patients With COVID-19

March 28, 2020
Teva Donates Medicines to Treat Patients With COVID-19

Israeli pharmaceutical giant Teva (in Bulgaria it operates under the name Actavis) has donated to the Ministry of Health 100 packs of hydroxychloroquine sulfate and 200 packages of products containing Azithromycin, to be used in treating patients infected with COVID-19.

"As soon as we learned about the potential benefits of using these medicines, Teva made an extraordinary effort to provide the quantities to the Ministry of Health in the shortest possible time. According to medical experts, the donated amount will be used for the potential treatment of nearly 100 patients, ”said Nikolay Hadzhidonchev, Executive Director of Actavis EAD.

Teva Pharmaceuticals is a global leader in the development and production of generic and innovative medicines

Following the acquisition of Actavis Generics by Teva, Actavis Generics, the company owns two of the largest pharmaceutical companies in our country - in Dupnitsa and Tpoyan. In Bulgaria, the company operates under the name Actavis.


More news